2m 2m 2m 2m 2m 2m 2m
Selct Med Hldgs (SEM)
NYSE
$16.57+$0.02 (+0.09%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.1BMarket Cap
- 13.13%1-Year Change
- Medical Care FacilitiesIndustry
Selct Med Hldgs (SEM)
$16.57+$0.02 (+0.09%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.5B +5.12% | 5.2B -22.16% | 6.7B +5.22% | 6.3B +2.08% | |
Cost of Revenue | 4.8B +5.93% | 4.6B -20.56% | 5.7B +2.35% | 5.6B +5.96% | |
Gross Profit | 629.3M -0.69% | 633.6M -32.02% | 932.0M +27.09% | 733.4M -20.23% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 140.3M -31.19% | 203.9M -2.32% | 208.7M +1.42% | 205.8M +1.57% | |
Total Operating Expenses | 5.1B +3.98% | 4.9B -19.45% | 6.1B +2.55% | 6.0B +5.75% | |
Operating Profit | 336.2M +25.29% | 268.3M -51.64% | 554.9M +37.59% | 403.3M -43.50% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -198.6M +17.46% | -169.1M +24.36% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -198.6M +17.46% | -169.1M +24.36% | |
Total Nonoperating Income and Expense | 401.2M +5.02% | 382.0M +92.32% | 198.6M +17.46% | 169.1M +24.36% | |
Income before Taxes | 272.7M +56.06% | 174.8M -54.29% | 382.4M +46.73% | 260.6M -58.62% | |
Income Taxes | 58.2M +30.00% | 44.8M -45.80% | 82.6M +32.09% | 62.6M -51.80% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 146.2M -31.69% | 214.0M -12.10% | 243.5M +53.14% | 159.0M -60.47% | |
Net Income from Continuing Operations Applicable to Common | 146.2M +123.33% | 65.5M -82.88% | 382.4M +46.73% | 260.6M -58.62% | |
Basic EPS and Net Income | 1.16 -30.12% | 1.66 -13.09% | 1.91 +55.28% | 1.23 -58.72% | |
Diluted EPS and Net Income | 1.16 -30.12% | 1.66 -13.09% | 1.91 +55.28% | 1.23 -58.72% | |
Basic Weighted Average Shares | 122.6M -1.58% | 124.6M +1.23% | 123.1M -1.22% | 124.6M -4.32% | |
Diluted Weighted Average Shares | 122.6M -1.58% | 124.6M +1.23% | 123.1M -1.22% | 124.6M -4.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 26.5M -55.57% | 59.7M -28.94% | 84.0M -14.20% | 97.9M +31.75% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 26.5M -55.57% | 59.7M -28.94% | 84.0M -14.20% | 97.9M +31.75% | |
Total Current Assets | 1.0B +0.54% | 1.0B -18.91% | 1.3B -1.08% | 1.3B +11.57% | |
Accumulated Depreciation | 1.3B +9.78% | 1.2B -18.49% | 1.4B +11.35% | 1.3B +12.52% | |
Property and Plant and Equipment and Net | 992.3M +13.77% | 872.2M -14.79% | 1.0B +2.21% | 1.0B +4.16% | |
Total Long-Term Assets | 414.4M +11.15% | 372.8M -1.04% | 376.7M +10.24% | 341.7M -4.20% | |
Total Assets | 5.9B +4.34% | 5.6B -27.07% | 7.7B +0.32% | 7.7B +4.15% | |
Income Taxes Payable | 112.2M +37.62% | 81.5M -43.72% | 144.8M -14.96% | 170.3M +18.06% | |
Total Short-Term Debt | 24.2M +19.48% | 20.3M -71.18% | 70.3M +58.57% | 44.4M +152.40% | |
Total Current Liabilities | 984.5M +0.70% | 977.7M -21.69% | 1.2B +8.08% | 1.2B -9.26% | |
Total Long-Term Debt | 1.8B +6.65% | 1.7B -52.85% | 3.6B -6.45% | 3.8B +7.84% | |
Total Long-Term Liabilities | 79.9M +9.34% | 73.0M -33.78% | 110.3M +3.93% | 106.1M -0.29% | |
Total Liabilities | 3.8B +5.68% | 3.6B -40.96% | 6.1B -2.54% | 6.3B +4.66% | |
Retained Earnings | 837.0M +8.68% | 770.1M +2.43% | 751.9M +29.41% | 581.0M -2.06% | |
Total Stockholders Equity | 1.7B +1.44% | 1.7B +30.51% | 1.3B +14.83% | 1.1B +1.08% | |
Total Shares Outstanding | 124.0M -3.83% | 129.0M +0.46% | 128.4M +0.94% | 127.2M -5.01% | |
Cash Flow | |||||
Cash from Operating Activities | 346.5M -33.10% | 517.9M -11.03% | 582.1M +104.36% | 284.8M -29.01% | |
Capital Expenditures | 229.2M +3.17% | 222.2M -3.06% | 229.2M +20.40% | 190.4M +5.45% | |
Cash from Investing Activities | -216.5M -6.29% | -231.0M -13.96% | -268.5M +18.62% | -226.3M -11.79% | |
Dividends Paid | 31.4M -51.35% | 64.6M +1.12% | 63.9M -1.06% | 64.6M +27.65% | |
Cash from Financing Activities | -163.2M -47.57% | -311.2M -4.98% | -327.5M +838.61% | -34.9M -94.61% | |
Financials Ratio | |||||
Gross Margin | 11.54% -5.53% | 12.22% -12.66% | 13.99% +20.79% | 11.58% -21.85% | |
Operating Margin | 6.17% +19.19% | 5.17% -37.88% | 8.33% +30.77% | 6.37% -44.65% | |
Return on Assets | 2.55% -20.73% | 3.22% +1.50% | 3.17% +49.86% | 2.12% -60.50% | |
Return on Equity | 8.63% -40.10% | 14.42% -28.66% | 20.20% +41.81% | 14.25% -61.56% | |
Revenue Growth | 5.12% +123.11% | -22.16% -524.69% | 5.22% +150.95% | 2.08% -82.90% | |
Current Ratio | 1.04 -0.16% | 1.04 +3.54% | 1.01 -8.47% | 1.10 +22.97% | |
Cash Ratio | 0.03 -55.97% | 0.06 -9.21% | 0.07 -20.64% | 0.08 +45.21% | |
Debt-to-Equity Ratio | 1.07 +5.28% | 1.02 -64.14% | 2.84 -17.89% | 3.46 +7.40% | |
Debt-to-Assets Ratio | 0.31 +2.36% | 0.31 -35.84% | 0.48 -6.01% | 0.51 +4.22% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow